Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07125144 · ClinicalTrials.gov registry record · NA

Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago

A NA study of Suicide and Suicidal Ideation, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT07125144: Recruiting NA study of Suicide and Suicidal Ideation, sponsored by University of Chicago.

NCT07125144 is a NA study of Suicide and Suicidal Ideation that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 300 participants, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07125144, a NA study of Suicide and Suicidal Ideation, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

Suicide has been the third leading cause of death for Black youth in the U.S since the 1980s and persists as a leading cause of death for Black youth today. For example, in 2018 suicide was reported as the 2nd leading cause of death among Black Americans ages 10 to14 years old. Findings yielded from recent queries indicate that the gap in suicides among Black males and female youth has narrowed in recent years. Despite these disturbing trends, a dearth persists in our understanding of the factors that contribute to and prevent against suicide in Black youth, thus diminishing researchers' ability to effectively detect suicide risk in this particular population. This project aims to redress this gap by proposing the cultural adaptation of an existing suicide prevention intervention, the Signs of Suicide (SOS) prevention program, for Black middle school students. Our team will conduct a pilot randomized controlled trial among a sample of Black middle school students to assess feasibility and examine underlying mechanisms that contribute to suicidality among Black youth. Intervention content will be adapted to assess how topics of racial identity, racial socialization, and racial discrimination uniquely impact Black youth's mental health experiences and risk for suicide. Measures of suicidal ideation, planning, and attempt will be assessed at pre-test, post-test, and 3-months after the intervention. Findings derived from this project will contribute to public health priorities by offering unique insight into the factors that either prevent or promote suicide among Black youth and could be replicated in other schools serving Black students across the nation.

Primary Outcome

Item that asks students to report if they have seriously considered suicide

Interventions

  • BEHAVIORAL Black Youth Suicide Prevention in Chicago
  • BEHAVIORAL Signs of Suicide: Standard/Existing

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-01-30
Est. Completion 2026-07-31
Phase NA
University of Chicago

796 total trials

What NCT07125144 shows while recruiting

NCT07125144 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 6,987-participant average among 92 other Suicide trials with a reported enrollment target (96% lower).

The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Black Youth Suicide Prevention in Chicago is the first listed.

NCT07125144 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT07125144 about?

NCT07125144 is a clinical study titled "Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago". Suicide has been the third leading cause of death for Black youth in the U.S since the 1980s and persists as a leading cause of death for Black youth today. For example, in 2018 suicide was reported as the 2nd leading cause of death among Black Americans ages 10 to14 years old. Findings yielded from...

What is the current status of trial NCT07125144?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-30. Estimated completion is 2026-07-31.

What conditions does trial NCT07125144 study?

This clinical trial studies the following conditions: Suicide, Suicidal Ideation, Suicide Attempt.

What interventions are being tested in trial NCT07125144?

The interventions under investigation include: Black Youth Suicide Prevention in Chicago (BEHAVIORAL), Signs of Suicide: Standard/Existing (BEHAVIORAL).

Who is sponsoring clinical trial NCT07125144?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07125144 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07125144's enrollment target sits among peer trials

300 25th of 92 higher than 67 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07125144, the US trial registry maintained by the National Library of Medicine. NCT07125144 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.